Emerald Bioscience Inc. is a biopharmaceutical company focused on the discovery and development of first-in-class molecules with strong clinical and commercial differentiation for conditions with significant, global, unmet medical needs. With proprietary technology licensed from the University of Mississippi, the Company is developing novel ways to deliver its synthetic cannabinoid-derived molecules for specific indications with the aim of optimizing therapeutic benefit. The Company’s aim is to clinically develop multiple proprietary compounds alone or in combination with corporate partners.
For Fiscal Year Ending Dec 31, 2019
Receive updates straight into your inbox
Emerald Bioscience, Inc.
5910 Pacific Center Blvd. Suite 320 San Diego, CA 92121
EMBI Investor Relations T: 949-396-0330 firstname.lastname@example.org
ClearTrust, LLC 16540 Pointe Village Dr. Suite 210 Lutz, FL 33558 T: 813-235-4490 www.ClearTrustOnline.com